Fortress Biotech FBIO
NASDAQ FBIO
$2.20 +0.03 (+1.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Fortress Biotech (FBIO) Convertible Debt (2021)

Updated

Fortress Biotech (FBIO) reported Convertible Debt of $18.08 million for Q3 2021, up 44.5% from the prior quarter.

Analysis

Fortress Biotech (FBIO) Convertible Debt (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Fortress Biotech 72.28 Mn -322.33 Mn 12.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 18.08 Mn
Jun 30, 2021 12.51 Mn
Mar 31, 2021 10.69 Mn
API Access

Fortress Biotech Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=FBIO&period=max&api_key=YOUR_API_KEY